Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Stephen Simpson

View as an RSS Feed
View Stephen Simpson's Articles BY TICKER:
A, ABB, ABT, ACHN, ACI, ADI, ADTN, AEP, AES, AET, AEZS, AGCO, AIMC, ALGN, ALKS, ALNY, ALPMY.PK, ALU, ALXN, AME, AMED, AMGN, AMRN, AMX, ANFI, ANGO, APNHY.PK, ARAY, ARCO, ARIA, ARQL, ASOMY.PK, ATHN, ATLKY.PK, ATRC, AUXL, AVGO, AZN, BA, BAC, BAX, BBT, BCR, BDX, BIIB, BIOD, BMRN, BMTI, BMY, BP, BRCD, BRFS, BRK.B, BSFT, BSX, BTU, C, CAT, CBD, CBST, CELG, CFN, CFX, CHKP, CLDX, CMA, CMI, CNH, COO, COP, COV, CPHD, CR, CSCO, CSII, CVGI, CVV, CVX, CYCC, DD, DE, DHR, DIS, DNDN, DUSA, EAC, ELGX, ELN, EMR, ENDP, ET, ETN, ETRM, EVAC, EW, EXAS, EXEL, FAST, FCFS, FCX, FET, FF, FFIV, FHN, FIRE, FMX, FOLD, FRCOY.PK, FRX, FSII, FUL, GBX, GE, GILD, GLEKY.PK, GLPW, GLW, GMAN, GMED, GNRC, GPRO, GRC, GSK, GTLS, GTOMY.PK, GTXI, HAL, HLF, HLUYY.PK, HNZ, HOCPY.PK, HOGS, HOLI, HOLX, HON, HRC, HRL, HSP, HTWR, HURC, HW, HYPMY.PK, IART, ICUI, IDIX, IIVI, ILMN, IMGN, INGIY.PK, IR, ISRG, ISTA, ITW, JCI, JNJ, JOY, JPM, K, KDN, KMTUY.PK, KOP, KRFT, LABL, LAWS, LECO, LHCG, LIFE, LLY, LMNX, LNCR, LPDX, LSI, LXRX, MAKO, MASI, MCD, MDCI, MDLZ, MDT, MEAS, MMM, MNTX, MON, MR, MRK, MSCC, MSFT, MSM, MTB, MTL, MTNOY.PK, MTRX, MTW, MYL, NAV, NBHGY.PK, NBIX, NKTR, NOK, NPO, NPSP, NUACF.PK, NUVA, NVO, NVS, ODFL, OMER, OSK, OZRK, PAA, PAY, PB, PCXCQ.OB, PEP, PFE, PG, PH, PLL, PMTI, PNC, POT, PRAA, PRIM, PRX, PVD, PWAV, QCOR, QSFT, RAVN, RDWR, RHHBY.OB, RIG, RIGL, SANW, SASR, SBMRY.PK, SCGLY.PK, SGEN, SHPG, SHS, SI, SKH, SLXP, SNCR, SNHY, SNMX, SNV, SNY, SPLK, SPNC, SPW, SSH, STB, STJ, STLD, SUMR, SWI, SWK, SYK, TC, TEAR, TEN, TEVA, TEX, TKC, TNGO, TRCR, TRGT, TRUMY.PK, TSRX, TWGP, TWI, TYPE, UNH, UPI, USB, UTEK, UTX, V, VICL, VMW, VOLC, VVUS, WFT, WLP, X, XLNX, XNPT, XOM, XPO, XRAY, XYL, YMI, ZION, ZIOP, ZMH, ZOLL
  • Does SABMiller Taste Great, Or Is The Valuation Too Filling?
    on Tue, Dec 11, 2012 BUD, KO, TAP 2 Comments
  • Can Amgen Unlock DeCODE's Value?
    on Mon, Dec 10, 2012 ILMN, MYGN, PFE 1 Comment
  • Should The Amylin Example Discourage Amarin Shareholders?
    on Fri, Dec 7, 2012 AZN, LLY, GSK 24 Comments
  • Can Labelmaker Multi-Color Make The Leverage Stick?
    on Fri, Dec 7, 2012 BMS, CCK, CL 2 Comments
  • Challenges Abound, But Overlooked Microsemi Should Be Ready To Deliver
    on Thu, Dec 6, 2012 SLAB, ARX, TXN Comment!
  • FEMSA May Just Be Getting Started
    on Wed, Dec 5, 2012 KO, KOF, PEP 5 Comments
  • BioMimetic Looks Like Serious Augmentation For Wright Medical
    on Mon, Dec 3, 2012 JNJ, MDT, SYK 7 Comments
  • Boston Scientific Offers More Muddle-Through
    on Thu, Oct 18, 2012 STJ, MDT, BSX 1 Comment
  • Stagnant Performance, FDA Issues Thump St. Jude
    on Thu, Oct 18, 2012 BSX, COV, MDT 12 Comments
  • Lexicon Pushes On To Phase III
    on Fri, Oct 12, 2012 JNJ, AZN, BMY 8 Comments
  • Will New Leadership Bring Evolution Or Revolution To Accuray?
    on Fri, Oct 12, 2012 SI, VAR, EKTAY.PK 3 Comments
  • Ingersoll-Rand And The Power Of Change
    on Thu, Oct 4, 2012 ATLKY.PK, DOV, JCI 5 Comments
  • Back To Square 1 For NuVasive?
    on Thu, Oct 4, 2012 ATEC, GMED, MDT 3 Comments
  • Don't Judge Monsanto By A Slow Quarter
    on Wed, Oct 3, 2012 ALNY, SYT, DD 6 Comments
  • Is ImmunoGen More Than T-DM1?
    on Tue, Oct 2, 2012 CLDX, RHHBY.OB, PFE 7 Comments
  • AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
    on Mon, Oct 1, 2012 BMRN, FRX, ONXX 15 Comments
  • Is Moody's Late To The Drug Party?
    on Mon, Oct 1, 2012 AZN, GSK, MRK Comment!
  • Is Biotech Getting Too Frothy? Investor Sentiment Suggests Irrational Exuberance
    on Mon, Oct 1, 2012 CELG, CLDX, REGN 26 Comments
  • SPX: A Complicated Power Play
    on Tue, Sep 25, 2012 ABB, GE, SI 3 Comments
  • Is There Room For One More Advanced Melanoma Treatment?
    on Tue, Sep 25, 2012 BMY, DNDN, MRK 8 Comments
  • Can Sun's Superiority Send It Higher?
    on Mon, Sep 24, 2012 ETN, MOG.A, PH 1 Comment
  • Here We Go Again With AEterna Zentaris... Again
    on Fri, Sep 21, 2012 CELG, KERX, RHHBY.OB 23 Comments
  • Achillion Back On The Hep C Roller Coaster Of Love
    on Wed, Sep 19, 2012 ABT, GILD, JNJ 7 Comments
  • Neurocrine Still Looks Significantly Underrated
    on Tue, Sep 18, 2012 ABT, NVS, LLY 4 Comments
  • Targacept Looking Like A Dead End
    on Mon, Sep 17, 2012 WCRX, AZN, BMY 2 Comments
  • NuVasive Could Do Better, But Will It?
    on Thu, Sep 13, 2012 GMED, SYK, JNJ 7 Comments
  • Med-Tech Due For More M&A
    on Wed, Sep 12, 2012 IART, VOLC, THOR 21 Comments
  • Ametek Deserves Its Premium
    on Tue, Sep 11, 2012 ABB, EMR, ETN 1 Comment
  • Keep A Close Eye On Cooper's Improvements
    on Mon, Sep 10, 2012 JNJ, LUX, NVS 1 Comment
  • Hurco Navigating A Tough Market Reasonably Well
    on Fri, Sep 7, 2012 ATLKY.PK, HDNG, LECO Comment!
  • Accuray's Quarter Not A Disaster, But Share Growth Is Still An Issue
    on Fri, Sep 7, 2012 VAR, SI, ARAY 6 Comments
  • Can Navistar Pull Itself Out Of The Ditch?
    on Thu, Sep 6, 2012 ETN, CMI, NAV 3 Comments